Boditech Med Inc 206640
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- KRW 16,800.00–17,620.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 17,420.00 / KRW 17,500.00
- Market Cap
- KRW 381.85 Bil
- Volume/Avg
- 137,583 / 176,799
Key Statistics
- Price/Earnings (Normalized)
- 13.96
- Price/Sales
- 2.84
- Dividend Yield (Trailing)
- 1.15%
- Dividend Yield (Forward)
- 1.15%
- Total Yield
- 1.15%
Company Profile
Boditech Med Inc is a pharmaceutical company which provides diagnostic solutions. It develops, manufactures and distributes products for in-vitro diagnostics and diagnostic reagents. The company is also developing a smart production system that integrates digital technology and IT technology. The firm develops its products for heart disease, cancer, diabetes, hormone, infection, and arthritis.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 472
- Website
- http://www.boditech.co.kr
Comparables
Valuation
|
Metric
|
206640
|
039200
|
314930
|
|---|---|---|---|
Price/Earnings (Normalized) | 13.96 | — | — |
Price/Book Value | 2.02 | 13.40 | 6.57 |
Price/Sales | 2.84 | 253.37 | 73.02 |
Price/Cash Flow | 9.42 | — | — |
Price/Earnings
206640
039200
314930
Financial Strength
|
Metric
|
206640
|
039200
|
314930
|
|---|---|---|---|
Quick Ratio | 3.86 | — | 33.73 |
Current Ratio | 5.09 | 2.73 | 35.00 |
Interest Coverage | 89.20 | −90.11 | −8,694.04 |
Quick Ratio
206640
039200
314930
Profitability
|
Metric
|
206640
|
039200
|
314930
|
|---|---|---|---|
Return on Assets (Normalized) | 13.00% | −20.27% | −2.51% |
Return on Equity (Normalized) | 15.76% | −25.17% | −2.56% |
Return on Invested Capital (Normalized) | 13.96% | −26.91% | −3.88% |
Return on Assets
206640
039200
314930
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Fpjhcqzmvh | Mfrrhw | $79.9 Bil | |
ZTS
| Zoetis Inc Class A | Ynpvzqvs | Xmvpm | $79.3 Bil | |
HLN
| Haleon PLC ADR | Jhtfmyhm | Xwd | $38.1 Bil | |
VTRS
| Viatris Inc | Jyzrdpwt | Ckth | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Yfjzrcwkf | Jfzxv | $11.7 Bil | |
CTLT
| Catalent Inc | Wqqfbrcs | Xyhwx | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Jnkvcjx | Nxhrq | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Lhqlpdd | Lwr | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Msyqfdn | Fbfzbt | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Jnfclzwkh | Cktbc | $3.1 Bil |